Korean J Thorac Cardiovasc Surg.  2005 Jan;38(1):38-43.

Activity of Matrix Metalloproteinase-2 and its Significance after Resection of Stage I Non-small Cell Lung Cancer

Affiliations
  • 1Cancer Research Center, Center for Clinical Research, Samsung Biomedical Research Institute, Korea.
  • 2Department of Biochemistry, College of Medicine, Ewha Womans University, Korea.
  • 3Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Korea. ysooyah@medimail.co.kr

Abstract

BACKGROUND: Matrix metalloproteinase-2 (MMP-2) is a class of proteolytic enzymes that digest collagen type IV and other components of the basement membrane. It plays a key role in the local invasion and the formation of distant metastases by various malignant tumors. The aim of this study was to evaluate the activity of MMP-2 and its significance as a prognostic marker in resected stage I non-small cell lung cancer (NSCLC). MATERIAL AND METHOD: In this study we obtained fresh-frozen samples of tumor and non-tumor tissues from 34 patients with stage I NSCLC who underwent resection without preoperative radiotherapy or chemotherapy. After the extraction of total protein from tissue samples, MMP-2 activities were assessed by gelatin-substrate-zymography. The activities were divided into the higher or lower groups. RESULT: The MMP-2 activities were higher in tumor tissues than in non-tumor tissues. The MMP-2 activity of non-tumor tissues in recurrent group was higher than in non-recurrent group (p<0.01). Also the patients with higher MMP-2 activity of non-tumor tissues showed poor 5 year survival (p<0.01).
CONCLUSION
This result indicates that the higher level of MMP-2 activity in the non-tumor tissue is associated with the recurrence and survival after the resection of stage I NSCLC. Therefore, MMP-2 activity in the non-tumor tissue could be used as a potential prognostic marker for the resected stage I-NSCLC.

Keyword

Lung neoplasms; Cell biology; Neoplasm proteins; Neoplasm outcomes

MeSH Terms

Basement Membrane
Carcinoma, Non-Small-Cell Lung*
Collagen Type IV
Drug Therapy
Humans
Lung Neoplasms
Matrix Metalloproteinase 2*
Neoplasm Metastasis
Neoplasm Proteins
Peptide Hydrolases
Radiotherapy
Recurrence
Collagen Type IV
Matrix Metalloproteinase 2
Neoplasm Proteins
Peptide Hydrolases
Full Text Links
  • KJTCS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr